Search research articles
Contact Us
Filters
Showing results (1-10 of 97) with videos related to
Page
of 10
Sort By:
Cancer Cytopathology
|
April 3, 2023
The "preexisting condition" invention in American health care: A lingering threat to preventive care: This second of a two-part series reveals how new research has detailed how expanded access to health insurance is aiding preventive care, and how further gains could be thwarted by unresolved insurance provisions: This second of a two-part series reveals how new research has detailed how expanded access to health insurance is aiding preventive care, and how further gains could be thwarted by unresolved insurance provisions
Bryn Nelson, William Faquin
Cancer Cytopathology
|
December 2, 2024
The deadliness of loneliness: Studies suggest that those who are lonely, isolated, or living alone may face a higher risk of cancer and cancer mortality-adding to the growing alarm and hunt for solutions
Bryn Nelson, William Faquin
Cancer Cytopathology
|
December 2, 2025
A new push to revive transperineal prostate biopsies: Amid growing concerns over transrectal biopsy infections and antibiotic resistance, the case for a transperineal alternative is not yet a sure thing
Bryn Nelson, William Faquin
Cancer Cytopathology
|
December 12, 2022
Cancer-linked genetic testing: Growing panels and challenges in the United States: In this first of a two-part series, genetic testing is promising more targeted approaches to prevention and intervention for hereditary cancers, but new recommendations are running up against communication challenges and differences even within the United States: In this first of a two-part series, genetic testing is promising more targeted approaches to prevention and intervention for hereditary cancers, but new recommendations are running up against communication challenges and differences even within the United States
Bryn Nelson, William Faquin
Cancer Cytopathology
|
June 19, 2025
Untangling the mystery of rising breast cancer rates: In this first of a two-part series on new investigations into rising breast and colorectal cancer rates, researchers are grappling with spiking rates of specific breast cancers, particularly among younger women
Bryn Nelson, William Faquin
Cancer Cytopathology
|
October 3, 2025
A daunting quest to map the reach and risk of nanoplastics: In this second of a two-part series on early studies of microplastics and nanoplastics, researchers have found tiny particles throughout the human body but warn that quantifying and reducing the risk may be difficult
Bryn Nelson, William Faquin
Cancer Cytopathology
|
February 3, 2024
Heightened but variable COVID-19 risks for patients with cancer: Multiple studies have underscored certain cancer-associated dangers while reaffirming the protective effects of vaccination and other prevention strategies
Bryn Nelson, William Faquin
Cancer Cytopathology
|
August 1, 2024
Exposing the naked truth about how mole-rats evade cancer: In this first of a two-part series on what we can learn from unusually cancer-resistant or -susceptible animals, researchers are exploring how adaptations to their extreme environment may have given naked mole-rats potent cancer-fighting tools
Bryn Nelson, William Faquin
Cancer Cytopathology
|
November 2, 2024
Cancer-aiding elements begin illuminating the genome's "dark matter": Within what was once deemed useless junk, virus-like retrotransposons, long noncoding RNAs, and other exotic molecules have emerged as beacons for cancer researchers
Bryn Nelson, William Faquin
Cancer Cytopathology
|
April 7, 2026
Bridging the global diversity gap in cancer genomics: Ambitious new collaborations are aiming to create valuable cancer genomics databases that better reflect real-world diversity
Bryn Nelson, William Faquin
Page
of 10
Search research articles
Search
Showing results (1-10 of 97) with videos related to
Sort By:
Page
of 10
Cancer Cytopathology
|
April 3, 2023
The "preexisting condition" invention in American health care: A lingering threat to preventive care: This second of a two-part series reveals how new research has detailed how expanded access to health insurance is aiding preventive care, and how further gains could be thwarted by unresolved insurance provisions: This second of a two-part series reveals how new research has detailed how expanded access to health insurance is aiding preventive care, and how further gains could be thwarted by unresolved insurance provisions
Bryn Nelson, William Faquin
Cancer Cytopathology
|
December 2, 2024
The deadliness of loneliness: Studies suggest that those who are lonely, isolated, or living alone may face a higher risk of cancer and cancer mortality-adding to the growing alarm and hunt for solutions
Bryn Nelson, William Faquin
Cancer Cytopathology
|
December 2, 2025
A new push to revive transperineal prostate biopsies: Amid growing concerns over transrectal biopsy infections and antibiotic resistance, the case for a transperineal alternative is not yet a sure thing
Bryn Nelson, William Faquin
Cancer Cytopathology
|
December 12, 2022
Cancer-linked genetic testing: Growing panels and challenges in the United States: In this first of a two-part series, genetic testing is promising more targeted approaches to prevention and intervention for hereditary cancers, but new recommendations are running up against communication challenges and differences even within the United States: In this first of a two-part series, genetic testing is promising more targeted approaches to prevention and intervention for hereditary cancers, but new recommendations are running up against communication challenges and differences even within the United States
Bryn Nelson, William Faquin
Cancer Cytopathology
|
June 19, 2025
Untangling the mystery of rising breast cancer rates: In this first of a two-part series on new investigations into rising breast and colorectal cancer rates, researchers are grappling with spiking rates of specific breast cancers, particularly among younger women
Bryn Nelson, William Faquin
Cancer Cytopathology
|
October 3, 2025
A daunting quest to map the reach and risk of nanoplastics: In this second of a two-part series on early studies of microplastics and nanoplastics, researchers have found tiny particles throughout the human body but warn that quantifying and reducing the risk may be difficult
Bryn Nelson, William Faquin
Cancer Cytopathology
|
February 3, 2024
Heightened but variable COVID-19 risks for patients with cancer: Multiple studies have underscored certain cancer-associated dangers while reaffirming the protective effects of vaccination and other prevention strategies
Bryn Nelson, William Faquin
Cancer Cytopathology
|
August 1, 2024
Exposing the naked truth about how mole-rats evade cancer: In this first of a two-part series on what we can learn from unusually cancer-resistant or -susceptible animals, researchers are exploring how adaptations to their extreme environment may have given naked mole-rats potent cancer-fighting tools
Bryn Nelson, William Faquin
Cancer Cytopathology
|
November 2, 2024
Cancer-aiding elements begin illuminating the genome's "dark matter": Within what was once deemed useless junk, virus-like retrotransposons, long noncoding RNAs, and other exotic molecules have emerged as beacons for cancer researchers
Bryn Nelson, William Faquin
Cancer Cytopathology
|
April 7, 2026
Bridging the global diversity gap in cancer genomics: Ambitious new collaborations are aiming to create valuable cancer genomics databases that better reflect real-world diversity
Bryn Nelson, William Faquin
Page
of 10